What is MyPeBS ?
MyPeBS (My Personal Breast Screening) is a major and ambitious project funded by the European Union. The aim of this unique international clinical trial is to compare a personalised risk-based screening strategy (based on each woman’s individual risk of developing breast cancer in the coming years) with the current standard screening in volunteer women aged between 40 and 70 recruited in 6 countries: Belgium, Spain, France, Israel, Italy and the UK.
The study enrolled 53,143 female participants between June 2019 and July 2023.
MyPeBS (My Personal Breast Screening) is a major ambitious European initiative. This unique international clinical study compares a personalised risk-based screening strategy (based on the individual women’s risk of developing breast cancer) to standard screening among 85,000 women aged 40 to 70 in 6 countries: Belgium, France, Israel, Italy, United Kingdom and Spain.
Animation video presenting the MyPeBS study
News
Eleven clinical trials that will shape medicine in 2025
Nature Medicine asks leading researchers to name their top clinical trial for 2025, from genetherapies for prion disease and sickle-cell disease to digital tools for cancer and mental health. 2024’s big winners were the pharmaceutical companies behind the blockbuster...
Thank you for participating and contributing to the success of the MyPeBS study!
Press release – The My PeBS Study / Belgium : “Advancing knowledge about breast cancer screening is essential”
October 20, 2022 – MyPeBS (My Personal Breast Cancer Screening) is a clinical study which aims to evaluate a breast cancer screening strategy based on individual risk. The clinical study, coordinated by Unicancer (France) involves 28 partners in 6 countries (Belgium,...
Partners
The MyPeBS study is supported by the French Health Insurance and the French National Cancer Institute (INCa), and has been approved by the Cancer Screening Strategic Committee chaired by the French General Director of Health.